Skip to main content
SpringerLink
Log in

Posttraumatic Hypopituitarism: Neuroendocrine Dysfunction and Treatment

  • Chapter
  • First Online:
Traumatic Brain Injury

  • 2157 Accesses

Abstract

Posttraumatic hypopituitarism (PTH) can occur following various modes of acquired brain injury at all levels of severity (i.e., mild, moderate, and severe). Chronic dysfunction of the pituitary axis is observed in approximately one-third of individuals who experience a moderate-to-severe traumatic brain injury (TBI). Many of the sequelae associated with TBI have typically been attributed to cortical and subcortical damage. However, analyses of the signs and symptoms of pituitary axis dysfunction suggest that in a significant proportion of patients with TBI, the observed cognitive, psychiatric, and physical/functioning impairments may actually be the result of abnormal growth hormone secretion and could potentially be reversed with growth hormone replacement therapy. Early diagnosis of PTH and subsequent treatment can improve outcomes; however, PTH typically is not identified or treated due to masking effects of impairments secondary to damage to brain parenchyma other than the pituitary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dams-O’Connor K, Gibbons LE, Bowen JD, McCurry SM, Larson EB, Crane PK. Risk for late-life re-injury, dementia and death among individuals with traumatic brain injury: a population-based study. J Neurol Neurosurg Psychiatry. 2013;84(2):177–82.

    Article  PubMed  Google Scholar 

  2. Selassie AW, McCarthy ML, Pickelsimer EE. The influence of insurance, race, and gender on emergency department disposition. Acad Emerg Med. 2003;10(11):1260–70.

    Article  PubMed  Google Scholar 

  3. Stein S. Classification of head injury. In: Narayan R, Povlishock J, Wilberger J, editors. Neurotrauma. New York: McGraw-Hill; 1996.

    Google Scholar 

  4. Brazil K. Assessing the consequences of traumatic brain injury. Int J Rehabil Res. 1992;15(2):93–101.

    Article  CAS  PubMed  Google Scholar 

  5. Fleminger S. Long-term psychiatric disorders after traumatic brain injury. Eur J Anaesthesiol Suppl. 2008;42:123–30.

    Article  CAS  PubMed  Google Scholar 

  6. Kosch Y, Browne S, King C, Fitzgerald J, Cameron I. Post-traumatic amnesia and its relationship to the functional outcome of people with severe traumatic brain injury. Brain Inj. 2010;24(3):479–85.

    Article  CAS  PubMed  Google Scholar 

  7. Wood RL, McHugh L. Decision making after traumatic brain injury: a temporal discounting paradigm. J Int Neuropsychol Soc. 2013;19(2):181–8.

    Article  PubMed  Google Scholar 

  8. Urban RJ, Harris P, Masel B. Anterior hypopituitarism following traumatic brain injury. Brain Inj. 2005;19(5):349–58.

    Article  CAS  PubMed  Google Scholar 

  9. Cyran E. Hypophysenschädigung durch Schädelbasisfraktur. Dtsch Med Wochenschr. 1918;44:1261.

    Google Scholar 

  10. Benvenga S, Campenni A, Ruggeri RM, Trimarchi F. Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab. 2000;85(4):1353–61.

    Article  CAS  PubMed  Google Scholar 

  11. Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ. Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab. 2001;86(6):2752–6.

    CAS  PubMed  Google Scholar 

  12. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg. 2000;93(5):743–52.

    Article  CAS  PubMed  Google Scholar 

  13. Gupta AK, Zygun DA, Johnston AJ, Steiner LA, Al-Rawi PG, Chatfield D, et al. Extracellular brain pH and outcome following severe traumatic brain injury. J Neurotrauma. 2004;21(6):678–84.

    Article  PubMed  Google Scholar 

  14. Masel BE, Urban R. Chronic endocrinopathies in traumatic brain injury disease. J Neurotrauma. 2015;32(23):1902–10.

    Article  PubMed  Google Scholar 

  15. Popovic V, Aimaretti G, Casanueva FF, Ghigo E. Hypopituitarism following traumatic brain injury. Growth Horm IGF Res. 2005;15(3):177–84.

    Article  CAS  PubMed  Google Scholar 

  16. de Boer H, Blok GJ, Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 1995;16(1):63–86.

    Article  PubMed  Google Scholar 

  17. Maison P, Chanson P. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation. 2003;108(21):2648–52.

    Article  CAS  PubMed  Google Scholar 

  18. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab. 1998;83(2):382–95.

    Article  CAS  PubMed  Google Scholar 

  19. High WM Jr, Briones-Galang M, Clark JA, Gilkison C, Mossberg KA, Zgaljardic DJ, et al. Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J Neurotrauma. 2010;27(9):1565–75.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bhagia V, Gilkison C, Fitts RH, Zgaljardic DJ, High WM Jr, Masel BE, et al. Effect of recombinant growth hormone replacement in a growth hormone deficient subject recovering from mild traumatic brain injury: a case report. Brain Inj. 2010;24(3):560–7.

    Article  PubMed  Google Scholar 

  21. Zgaljardic DJ, Guttikonda S, Grady JJ, Gilkison CR, Mossberg KA, High WM Jr, et al. Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing. Clin Endocrinol (Oxf). 2011;74(3):365–9.

    Article  CAS  Google Scholar 

  22. Daniel PM, Prichard MM, Treip CS. Traumatic infarction of the anterior lobe of the pituitary gland. Lancet. 1959;2(7109):927–31.

    Article  CAS  PubMed  Google Scholar 

  23. Melmed S, Polonsky K, Larsen R, Kronenberg H. Williams textbook of endocrinology. 13th ed. Philadelphia: Elsevier; 2016.

    Google Scholar 

  24. Ghigo E, Masel B, Aimaretti G, Leon-Carrion J, Casanueva FF, Dominguez-Morales MR, et al. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj. 2005;19(9):711–24.

    Article  CAS  PubMed  Google Scholar 

  25. Thompson C. Traumatic brain injury-induced hypopituitarism: whom and when to test. Endocr Abstr. 2007;14(S1.1).

    Google Scholar 

  26. Behan LA, Phillips J, Thompson CJ, Agha A. Neuroendocrine disorders after traumatic brain injury. J Neurol Neurosurg Psychiatry. 2008;79(7):753–9.

    Article  CAS  PubMed  Google Scholar 

  27. Bondanelli M, Ambrosio MR, Cavazzini L, Bertocchi A, Zatelli MC, Carli A, et al. Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. J Neurotrauma. 2007;24(11):1687–97.

    Article  PubMed  Google Scholar 

  28. Cohan P, Wang C, McArthur DL, Cook SW, Dusick JR, Armin B, et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med. 2005;33(10):2358–66.

    Article  CAS  PubMed  Google Scholar 

  29. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 1992;37(5):387–97.

    Article  CAS  Google Scholar 

  30. Klose M, Feldt-Rasmussen U. Does the type and severity of brain injury predict hypothalamo-pituitary dysfunction? Does post-traumatic hypopituitarism predict worse outcome? Pituitary. 2008;11(3):255–61.

    Article  CAS  PubMed  Google Scholar 

  31. Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J Neurotrauma. 2010;27(8):1529–40.

    Article  PubMed  Google Scholar 

  32. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA. 2007;298(12):1429–38.

    Article  CAS  PubMed  Google Scholar 

  33. Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 2002;12(10):839–47.

    Article  PubMed  Google Scholar 

  34. Agha A, Rogers B, Sherlock M, O’Kelly P, Tormey W, Phillips J, et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab. 2004;89(10):4929–36.

    Article  CAS  PubMed  Google Scholar 

  35. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C, et al. Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab. 2005;90(11):6085–92.

    Article  CAS  PubMed  Google Scholar 

  36. Bondanelli M, De Marinis L, Ambrosio MR, Monesi M, Valle D, Zatelli MC, et al. Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma. 2004;21(6):685–96.

    Article  PubMed  Google Scholar 

  37. Herrmann BL, Rehder J, Kahlke S, Wiedemayer H, Doerfler A, Ischebeck W, et al. Hypopituitarism following severe traumatic brain injury. Exp Clin Endocrinol Diabetes. 2006;114(6):316–21.

    Article  CAS  PubMed  Google Scholar 

  38. Klose M, Watt T, Brennum J, Feldt-Rasmussen U. Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury. J Clin Endocrinol Metab. 2007;92(10):3861–8.

    Article  CAS  PubMed  Google Scholar 

  39. Kreber LA, Griesbach GS, Ashley MJ. Detection of growth hormone deficiency in adults with chronic traumatic brain injury. J Neurotrauma. 2015;33(17):1607–13.

    Article  PubMed  Google Scholar 

  40. Leal-Cerro A, Flores JM, Rincon M, Murillo F, Pujol M, Garcia-Pesquera F, et al. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Clin Endocrinol (Oxf). 2005;62(5):525–32.

    Article  CAS  Google Scholar 

  41. Popovic V, Pekic S, Pavlovic D, Maric N, Jasovic-Gasic M, Djurovic B, et al. Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J Endocrinol Invest. 2004;27(11):1048–54.

    Article  CAS  PubMed  Google Scholar 

  42. Schneider HJ, Schneider M, Saller B, Petersenn S, Uhr M, Husemann B, et al. Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol. 2006;154(2):259–65.

    Article  CAS  PubMed  Google Scholar 

  43. Tanriverdi F, Senyurek H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J Clin Endocrinol Metab. 2006;91(6):2105–11.

    Article  CAS  PubMed  Google Scholar 

  44. Krahulik D, Zapletalova J, Frysak Z, Vaverka M. Dysfunction of hypothalamic-hypophysial axis after traumatic brain injury in adults. J Neurosurg. 2010;113(3):581–4.

    Article  PubMed  Google Scholar 

  45. Schneider HJ, Schneider M, Kreitschmann-Andermahr I, Tuschy U, Wallaschofski H, Fleck S, et al. Structured assessment of hypopituitarism after traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1242 patients: the German interdisciplinary database. J Neurotrauma. 2011;28(9):1693–8.

    Article  PubMed  Google Scholar 

  46. Ives JC, Alderman M, Stred SE. Hypopituitarism after multiple concussions: a retrospective case study in an adolescent male. J Athl Train. 2007;42(3):431–9.

    PubMed  PubMed Central  Google Scholar 

  47. Tanriverdi F, Ulutabanca H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. Three years prospective investigation of anterior pituitary function after traumatic brain injury: a pilot study. Clin Endocrinol (Oxf). 2008;68(4):573–9.

    Article  CAS  Google Scholar 

  48. Kelly DF, Chaloner C, Evans D, Mathews A, Cohan P, Wang C, et al. Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma. 2014;31(13):1161–71.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Wilkinson CW, Pagulayan KF, Petrie EC, Mayer CL, Colasurdo EA, Shofer JB, et al. High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury. Front Neurol. 2012;3:11.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Hannon MJ, Sherlock M, Thompson CJ. Pituitary dysfunction following traumatic brain injury or subarachnoid haemorrhage – in “Endocrine Management in the Intensive Care Unit”. Best Pract Res Clin Endocrinol Metab. 2011;25(5):783–98.

    Article  CAS  PubMed  Google Scholar 

  51. Ho KK, 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007;157(6):695–700.

    Article  CAS  PubMed  Google Scholar 

  52. Tritos NA, Yuen KC, Kelly DF, AACE Neuroendocrine and Pituitary Scientific Committee. American association of clinical endocrinologists and American college of endocrinology disease state clinical review: a neuroendocrine approach to patients with traumatic brain injury. Endocr Pract. 2015;21(7):823–31.

    Article  PubMed  Google Scholar 

  53. Urban RJ. Hypopituitarism after acute brain injury. Growth Horm IGF Res. 2006;16 Suppl A:S25–9.

    Article  PubMed  CAS  Google Scholar 

  54. Fernandez-Rodriguez E, Bernabeu I, Castro AI, Kelestimur F, Casanueva FF. Hypopituitarism following traumatic brain injury: determining factors for diagnosis. Front Endocrinol (Lausanne). 2011;2:25.

    Article  Google Scholar 

  55. Rothman MS, Arciniegas DB, Filley CM, Wierman ME. The neuroendocrine effects of traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2007;19(4):363–72.

    Article  CAS  PubMed  Google Scholar 

  56. Lissett CA, Jonsson P, Monson JP, Shalet SM, Board KI. Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD. Clin Endocrinol (Oxf). 2003;59(6):773–8.

    Article  CAS  Google Scholar 

  57. Rosario ER, Aqeel R, Brown MA, Sanchez G, Moore C, Patterson D. Hypothalamic-pituitary dysfunction following traumatic brain injury affects functional improvement during acute inpatient rehabilitation. J Head Trauma Rehabil. 2013;28(5):390–6.

    Article  PubMed  Google Scholar 

  58. Casanueva FF, Castro AI, Micic D, Kelestimur F, Dieguez C. New guidelines for the diagnosis of growth hormone deficiency in adults. Horm Res. 2009;71(Suppl 1):112–5.

    CAS  PubMed  Google Scholar 

  59. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002;87(5):2067–79.

    Article  CAS  PubMed  Google Scholar 

  60. Jones SL, Trainer PJ, Perry L, Wass JA, Besser GM, Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf). 1994;41(1):123–8.

    Article  CAS  Google Scholar 

  61. Yuen KC, Biller BM, Molitch ME, Cook DM. Clinical review: is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab. 2009;94(8):2702–7.

    Article  CAS  PubMed  Google Scholar 

  62. Gomez JM, Espadero RM, Escobar-Jimenez F, Hawkins F, Pico A, Herrera-Pombo JL, et al. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol (Oxf). 2002;56(3):329–34.

    Article  CAS  Google Scholar 

  63. Conceicao FL, da Costa e Silva A, Leal Costa AJ, Vaisman M. Glucagon stimulation test for the diagnosis of GH deficiency in adults. J Endocrinol Invest. 2003;26(11):1065–70.

    Article  CAS  PubMed  Google Scholar 

  64. Gabellieri E, Chiovato L, Lage M, Castro AI, Casanueva FF. Testing growth hormone deficiency in adults. Front Horm Res. 2010;38:139–44.

    Article  CAS  PubMed  Google Scholar 

  65. Wilson JT. The relationship between neuropsychological function and brain damage detected by neuroimaging after closed head injury. Brain Inj. 1990;4(4):349–63.

    Article  CAS  PubMed  Google Scholar 

  66. McAllister TW. Neuropsychiatric sequelae of head injuries. Psychiatr Clin North Am. 1992;15(2):395–413.

    Article  CAS  PubMed  Google Scholar 

  67. Draper K, Ponsford J. Cognitive functioning ten years following traumatic brain injury and rehabilitation. Neuropsychology. 2008;22(5):618–25.

    Article  PubMed  Google Scholar 

  68. Maric NP, Doknic M, Pavlovic D, Pekic S, Stojanovic M, Jasovic-Gasic M, et al. Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy. J Endocrinol Invest. 2010;33(11):770–5.

    Article  CAS  PubMed  Google Scholar 

  69. Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA, et al. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab. 1998;83(9):3184–9.

    CAS  PubMed  Google Scholar 

  70. Bengtsson BA. The consequences of growth hormone deficiency in adults. Acta Endocrinol. 1993;128(Suppl 2):2–5.

    Google Scholar 

  71. Deijen JB, de Boer H, Blok GJ, van der Veen EA. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology. 1996;21(3):313–22.

    Article  CAS  PubMed  Google Scholar 

  72. Lijffijt M, Van Dam PS, Kenemans JL, Koppeschaar HP, de Vries WR, Drent ML, et al. Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients. Neurosci Lett. 2003;353(2):123–6.

    Article  CAS  PubMed  Google Scholar 

  73. Peace KA, Orme SM, Padayatty SJ, Godfrey HP, Belchetz PE. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin Endocrinol (Oxf). 1998;49(3):391–6.

    Article  CAS  Google Scholar 

  74. van Dam PS, de Winter CF, de Vries R, van der Grond J, Drent ML, Lijffijt M, et al. Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate. Psychoneuroendocrinology. 2005;30(4):357–63.

    Article  PubMed  CAS  Google Scholar 

  75. van Nieuwpoort IC, Drent ML. Cognition in the adult with childhood-onset GH deficiency. Eur J Endocrinol. 2008;159(Suppl 1):S53–7.

    Article  PubMed  CAS  Google Scholar 

  76. Wamstad JB, Norwood KW, Rogol AD, Gurka MJ, Deboer MD, Blackman JA, et al. Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: a preliminary study. Brain Inj. 2013;27(2):200–8.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Kelly DF, McArthur DL, Levin H, Swimmer S, Dusick JR, Cohan P, et al. Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury. J Neurotrauma. 2006;23(6):928–42.

    Article  PubMed  Google Scholar 

  78. Leon-Carrion J, Leal-Cerro A, Cabezas FM, Atutxa AM, Gomez SG, Cordero JM, et al. Cognitive deterioration due to GH deficiency in patients with traumatic brain injury: a preliminary report. Brain Inj. 2007;21(8):871–5.

    Article  CAS  PubMed  Google Scholar 

  79. Le Greves M, Zhou Q, Berg M, Le Greves P, Fholenhag K, Meyerson B, et al. Growth hormone replacement in hypophysectomized rats affects spatial performance and hippocampal levels of NMDA receptor subunit and PSD-95 gene transcript levels. Exp Brain Res. 2006;173(2):267–73.

    Article  CAS  PubMed  Google Scholar 

  80. Mahmoud GS, Grover LM. Growth hormone enhances excitatory synaptic transmission in area CA1 of rat hippocampus. J Neurophysiol. 2006;95(5):2962–74.

    Article  CAS  PubMed  Google Scholar 

  81. Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal. 2006;6:53–80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  82. Lichtenwalner RJ, Forbes ME, Sonntag WE, Riddle DR. Adult-onset deficiency in growth hormone and insulin-like growth factor-I decreases survival of dentate granule neurons: insights into the regulation of adult hippocampal neurogenesis. J Neurosci Res. 2006;83(2):199–210.

    Article  CAS  PubMed  Google Scholar 

  83. Devesa J, Reimunde P, Devesa P, Barbera M, Arce V. Growth hormone (GH) and brain trauma. Horm Behav. 2013;63(2):331–44.

    Article  CAS  PubMed  Google Scholar 

  84. Reeves RR, Panguluri RL. Neuropsychiatric complications of traumatic brain injury. J Psychosoc Nurs Ment Health Serv. 2011;49(3):42–50.

    PubMed  Google Scholar 

  85. Zgaljardic D, Schaefer L. Neurology and neuropsychology. In: Hunter C, Kessler R, Hunter C, editors. Handbook of clinical psychology in medical settings: evidence-based assessment and intervention. New York: Springer-Verlag Publications; 2014.

    Google Scholar 

  86. Seel RT, Kreutzer JS. Depression assessment after traumatic brain injury: an empirically based classification method. Arch Phys Med Rehabil. 2003;84(11):1621–8.

    Article  PubMed  Google Scholar 

  87. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–105.

    Article  PubMed  Google Scholar 

  88. Ashman TA, Spielman LA, Hibbard MR, Silver JM, Chandna T, Gordon WA. Psychiatric challenges in the first 6 years after traumatic brain injury: cross-sequential analyses of Axis I disorders. Arch Phys Med Rehabil. 2004;85(4 Suppl 2):S36–42.

    Article  PubMed  Google Scholar 

  89. Zgaljardic DJ, Seale GS, Schaefer LA, Temple RO, Foreman J, Elliott TR. Psychiatric disease and post-acute traumatic brain injury. J Neurotrauma. 2015;32(23):1911–25.

    Article  PubMed  Google Scholar 

  90. Jorge RE, Robinson RG, Starkstein SE, Arndt SV. Depression and anxiety following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 1993;5(4):369–74.

    Article  CAS  PubMed  Google Scholar 

  91. Jorge RE, Starkstein SE. Pathophysiologic aspects of major depression following traumatic brain injury. J Head Trauma Rehabil. 2005;20(6):475–87.

    Article  PubMed  Google Scholar 

  92. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358(1):55–68.

    Article  CAS  PubMed  Google Scholar 

  93. Nyberg F, Hallberg M. Growth hormone and cognitive function. Nat Rev Endocrinol. 2013;9(6):357–65.

    Article  CAS  PubMed  Google Scholar 

  94. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 1999;45(9):1085–98.

    Article  CAS  PubMed  Google Scholar 

  95. Jha A, Weintraub A, Allshouse A, Morey C, Cusick C, Kittelson J, et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil. 2008;23(1):52–63.

    Article  PubMed  Google Scholar 

  96. Belmont A, Agar N, Hugeron C, Gallais B, Azouvi P. Fatigue and traumatic brain injury. Ann Readapt Med Phys. 2006;49(6):283–8, 370–4.

    Article  CAS  PubMed  Google Scholar 

  97. Johansson B, Berglund P, Ronnback L. Mental fatigue and impaired information processing after mild and moderate traumatic brain injury. Brain Inj. 2009;23(13–14):1027–40.

    Article  PubMed  Google Scholar 

  98. Leavitt VM, DeLuca J. Central fatigue: issues related to cognition, mood and behavior, and psychiatric diagnoses. PM R. 2010;2(5):332–7.

    Article  PubMed  Google Scholar 

  99. Zgaljardic DJ, Durham WJ, Mossberg KA, Foreman J, Joshipura K, Masel BE, et al. Neuropsychological and physiological correlates of fatigue following traumatic brain injury. Brain Inj. 2014;28(4):389–97.

    Article  PubMed  Google Scholar 

  100. Ponsford JL, Ziino C, Parcell DL, Shekleton JA, Roper M, Redman JR, et al. Fatigue and sleep disturbance following traumatic brain injury--their nature, causes, and potential treatments. J Head Trauma Rehabil. 2012;27(3):224–33.

    Article  PubMed  Google Scholar 

  101. Clayton P, Gleeson H, Monson J, Popovic V, Shalet SM, Christiansen JS. Growth hormone replacement throughout life: insights into age-related responses to treatment. Growth Horm IGF Res. 2007;17(5):369–82.

    Article  CAS  PubMed  Google Scholar 

  102. Copinschi G, Nedeltcheva A, Leproult R, Morselli LL, Spiegel K, Martino E, et al. Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiency. J Clin Endocrinol Metab. 2010;95(5):2195–202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Stouthart PJ, Deijen JB, Roffel M, Delemarre-van de Waal HA. Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psychoneuroendocrinology. 2003;28(5):612–26.

    Article  CAS  PubMed  Google Scholar 

  104. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev. 2006;27(3):287–317.

    Article  CAS  PubMed  Google Scholar 

  105. Thomas SG, Esposito JG, Ezzat S. Exercise training benefits growth hormone (GH)-deficient adults in the absence or presence of GH treatment. J Clin Endocrinol Metab. 2003;88(12):5734–8.

    Article  CAS  PubMed  Google Scholar 

  106. Berwaerts J, Moorkens G, Abs R. Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Horm IGF Res. 1998;8(Suppl B):127–9.

    Article  PubMed  Google Scholar 

  107. Cuatrecasas G. Fibromyalgic syndromes: could growth hormone therapy be beneficial? Pediatr Endocrinol Rev. 2009;6(Suppl 4):529–33.

    PubMed  Google Scholar 

  108. Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Sola J, Casanueva FF, et al. High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab. 2010;95(9):4331–7.

    Article  CAS  PubMed  Google Scholar 

  109. Leal-Cerro A, Povedano J, Astorga R, Gonzalez M, Silva H, Garcia-Pesquera F, et al. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab. 1999;84(9):3378–81.

    CAS  PubMed  Google Scholar 

  110. Yuen KC, Bennett RM, Hryciw CA, Cook MB, Rhoads SA, Cook DM. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels? Growth Horm IGF Res. 2007;17(1):82–8.

    Article  CAS  PubMed  Google Scholar 

  111. Makimura H, Feldpausch MN, Stanley TL, Sun N, Grinspoon SK. Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size. Clin Endocrinol (Oxf). 2011;76(2):220–7.

    Article  CAS  Google Scholar 

  112. Short KR, Moller N, Bigelow ML, Coenen-Schimke J, Nair KS. Enhancement of muscle mitochondrial function by growth hormone. J Clin Endocrinol Metab. 2008;93(2):597–604.

    Article  CAS  PubMed  Google Scholar 

  113. Mossberg KA, Orlander EE, Norcross JL. Cardiorespiratory capacity after weight-supported treadmill training in patients with traumatic brain injury. Phys Ther. 2008;88(1):77–87.

    Article  PubMed  Google Scholar 

  114. Blair JC. Prevalence, natural history and consequences of posttraumatic hypopituitarism: a case for endocrine surveillance. Br J Neurosurg. 2010;24(1):10–7.

    Article  PubMed  Google Scholar 

  115. Masel BE. Rehabilitation and hypopituitarism after traumatic brain injury. Growth Horm IGF Res. 2004;14(Suppl A):S108–13.

    Article  PubMed  Google Scholar 

  116. Agha A, Thompson CJ. High risk of hypogonadism after traumatic brain injury: clinical implications. Pituitary. 2005;8(3–4):245–9.

    Article  PubMed  Google Scholar 

  117. Bondanelli M, Ambrosio MR, Zatelli MC, De Marinis L, degli Uberti EC. Hypopituitarism after traumatic brain injury. Eur J Endocrinol. 2005;152(5):679–91.

    Article  CAS  PubMed  Google Scholar 

  118. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001;357(9254):425–31.

    Article  CAS  PubMed  Google Scholar 

  119. Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, et al. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab. 1996;81(10):3654–62.

    CAS  PubMed  Google Scholar 

  120. Swerdloff RS, Wang C. Androgen deficiency and aging in men. West J Med. 1993;159(5):579–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  121. Costa MM, Reus VI, Wolkowitz OM, Manfredi F, Lieberman M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol Psychiatry. 1999;46(2):182–8.

    Article  CAS  PubMed  Google Scholar 

  122. Jacobs DM, Tang MX, Stern Y, Sano M, Marder K, Bell KL, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 1998;50(2):368–73.

    Article  CAS  PubMed  Google Scholar 

  123. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf). 1992;37(1):79–87.

    Article  CAS  Google Scholar 

  124. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, et al. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab. 1999;84(6):1919–24.

    CAS  PubMed  Google Scholar 

  125. Crespo I, Valassi E, Santos A, Webb SM. Health-related quality of life in pituitary diseases. Endocrinol Metab Clin North Am. 2015;44(1):161–70.

    Article  PubMed  Google Scholar 

  126. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol (1985). 1991;70(2):695–700.

    Article  CAS  Google Scholar 

  127. Ioachimescu AG, Hampstead BM, Moore A, Burgess E, Phillips LS. Growth hormone deficiency after mild combat-related traumatic brain injury. Pituitary. 2015;18(4):535–41.

    Article  CAS  PubMed  Google Scholar 

  128. Bjork S, Jonsson B, Westphal O, Levin JE. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand Suppl. 1989;356:55–9; discussion 60, 73–4.

    Article  CAS  PubMed  Google Scholar 

  129. Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D, et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab. 1993;77(6):1658–61.

    CAS  PubMed  Google Scholar 

  130. Beshyah SA, Johnston DG. Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol (Oxf). 1999;50(1):1–15.

    Article  CAS  Google Scholar 

  131. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336(8710):285–8.

    Article  CAS  PubMed  Google Scholar 

  132. Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab. 1997;82(9):2877–84.

    CAS  PubMed  Google Scholar 

  133. Nass R, Huber RM, Klauss V, Muller OA, Schopohl J, Strasburger CJ. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab. 1995;80(2):552–7.

    CAS  PubMed  Google Scholar 

  134. Moreau OK, Cortet-Rudelli C, Yollin E, Merlen E, Daveluy W, Rousseaux M. Growth hormone replacement therapy in patients with traumatic brain injury. J Neurotrauma. 2013;30(11):998–1006.

    Article  PubMed  Google Scholar 

  135. Reimunde P, Quintana A, Castanon B, Casteleiro N, Vilarnovo Z, Otero A, et al. Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury. Brain Inj. 2011;25(1):65–73.

    Article  CAS  PubMed  Google Scholar 

  136. Mossberg K, Durham W, Zgaljardic D, Gilkison C, Danesi C, Sheffield-Moore M, et al. Functional changes after recombinant human growth hormone replacement in patients with traumatic brain injury and abnormal growth hormone secretion. J Neurotrauma. 2017;34(4):845–52.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Durham WJ, Foreman JP, Randolph KM, Danesi CP, Spratt H, Masel BD, et al. Hypoaminoacidemia characterizes chronic traumatic brain injury. J Neurotrauma. 2017;34(2):385–90.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuropsychology, The Transitional Learning Center at Galveston, Galveston, TX, USA

    Dennis J. Zgaljardic

  2. Center for Neuro Skills, Bakersfield, CA, USA

    Lisa Kreber

  3. The Transitional Learning Center at Galveston, Galveston, TX, USA

    Jack Foreman

  4. Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA

    Randall Urban

Authors
  1. Dennis J. Zgaljardic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa Kreber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jack Foreman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Randall Urban
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dennis J. Zgaljardic .

Editor information

Editors and Affiliations

  1. The University of Tennessee Health Science Center, Memphis, TN, USA

    Jack W. Tsao

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zgaljardic, D.J., Kreber, L., Foreman, J., Urban, R. (2020). Posttraumatic Hypopituitarism: Neuroendocrine Dysfunction and Treatment. In: Tsao, J. (eds) Traumatic Brain Injury. Springer, Cham. https://doi.org/10.1007/978-3-030-22436-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22436-3_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22435-6

  • Online ISBN: 978-3-030-22436-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation